According to Harvard Bioscience's latest financial reports the company's current earnings are NZ$87.37 Million. In 2024 the company made an earning of -NZ$20.2 Million a decrease over its 2023 earnings that were of -NZ$4.43 Million. The earnings displayed on this page is the company's Pretax Income.